EE9700241A - Farmatseutiline kompositsioon transdermaalseks manustamiseks - Google Patents

Farmatseutiline kompositsioon transdermaalseks manustamiseks

Info

Publication number
EE9700241A
EE9700241A EE9700241A EE9700241A EE9700241A EE 9700241 A EE9700241 A EE 9700241A EE 9700241 A EE9700241 A EE 9700241A EE 9700241 A EE9700241 A EE 9700241A EE 9700241 A EE9700241 A EE 9700241A
Authority
EE
Estonia
Prior art keywords
pharmaceutical composition
transdermal administration
transdermal
administration
pharmaceutical
Prior art date
Application number
EE9700241A
Other languages
English (en)
Estonian (et)
Inventor
Saunal Henry
Illel Brigitte
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9477595&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE9700241(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi filed Critical Sanofi
Publication of EE9700241A publication Critical patent/EE9700241A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S602/00—Surgery: splint, brace, or bandage
    • Y10S602/904—Film-forming bandage material

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EE9700241A 1995-03-30 1996-03-29 Farmatseutiline kompositsioon transdermaalseks manustamiseks EE9700241A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9503776A FR2732223B1 (fr) 1995-03-30 1995-03-30 Composition pharmaceutique pour administration transdermique
PCT/FR1996/000480 WO1996030000A1 (fr) 1995-03-30 1996-03-29 Composition pharmaceutique filmogene pour administration transdermique

Publications (1)

Publication Number Publication Date
EE9700241A true EE9700241A (et) 1998-04-15

Family

ID=9477595

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700241A EE9700241A (et) 1995-03-30 1996-03-29 Farmatseutiline kompositsioon transdermaalseks manustamiseks

Country Status (33)

Country Link
US (1) US6010716A (es)
EP (1) EP0817621B2 (es)
JP (1) JP3778937B2 (es)
KR (1) KR100260237B1 (es)
CN (1) CN1108790C (es)
AR (1) AR001458A1 (es)
AT (1) ATE202280T1 (es)
AU (1) AU704150B2 (es)
BR (1) BR9607862A (es)
CA (1) CA2214845C (es)
CY (1) CY2280B1 (es)
CZ (1) CZ291914B6 (es)
DE (1) DE69613463T3 (es)
DK (1) DK0817621T4 (es)
EE (1) EE9700241A (es)
ES (1) ES2160239T5 (es)
FR (1) FR2732223B1 (es)
GR (1) GR3036630T3 (es)
HU (1) HU227957B1 (es)
IL (1) IL117728A (es)
IS (1) IS2537B (es)
MX (1) MX9707434A (es)
NO (1) NO323583B1 (es)
NZ (1) NZ305893A (es)
PL (1) PL186004B1 (es)
PT (1) PT817621E (es)
RU (1) RU2161957C2 (es)
SI (1) SI0817621T2 (es)
SK (1) SK282634B6 (es)
TR (1) TR199701083T1 (es)
TW (1) TW442296B (es)
WO (1) WO1996030000A1 (es)
ZA (1) ZA962536B (es)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4241706C2 (de) * 1992-12-10 1997-03-20 Ahlmann Aco Severin Befestigungseinrichtung für die Abdeckung einer Oberflächenentwässerungseinrichtung
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US6998138B2 (en) 1996-02-19 2006-02-14 Acrux Dds Pty. Ltd. Topical delivery of anti-alopecia agents
US6916487B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics
US6916486B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
US7094422B2 (en) 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
DE19616539A1 (de) * 1996-04-25 1997-11-06 Luitpold Pharma Gmbh Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel
US5955097A (en) * 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
AUPO379596A0 (en) * 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
DE19742275A1 (de) * 1997-09-25 1999-04-01 Beiersdorf Ag Estern verzweigtkettiger Carbonsäuren und verzweigtkettiger Alkohole als antibakterielle, antimycotische, antiparasitäre oder antivirale Wirkstoffe
PL346238A1 (en) 1998-08-20 2002-01-28 3M Innovative Properties Co Spray on bandage and drug delivery system
US6503488B1 (en) * 1998-11-17 2003-01-07 Tend Skin International, Inc. Topical compositions including deodorant compositions
FR2787712B1 (fr) * 1998-12-24 2002-08-30 Sanofi Sa Composition cosmetique pulverisable et matrice utilisable dans cette composition pour une administration dermique
ID30353A (id) * 1999-02-05 2001-11-22 Cipla Ltd Obat semprot topikal
AU4543200A (en) * 1999-04-16 2000-11-02 Dittgen, Michael Pharmaceutical or cosmetic compositions for the local, intradermal application of hormones
US6962691B1 (en) 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
AUPQ419099A0 (en) * 1999-11-23 1999-12-16 Ko, Thomas Sai Ying Novel compositions and methods
DE10019311A1 (de) * 2000-04-19 2001-10-31 Lohmann Therapie Syst Lts Transdermale therapuetische Systeme zur Applikation von Moxonidin
FR2808685B1 (fr) * 2000-05-12 2004-10-08 Sanofi Synthelabo Compositions pharmaceutiques pour administration transdermique d'agents anti-inflammatoires
DE10025971B4 (de) * 2000-05-25 2004-09-02 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US6479076B2 (en) * 2001-01-12 2002-11-12 Izhak Blank Nicotine delivery compositions
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
WO2002092069A1 (en) * 2001-05-11 2002-11-21 Elan Corporation, Plc Permeation enhancers
NZ530278A (en) * 2001-06-01 2006-06-30 Tendskin Company Topical composition containing a salicylate derivative for veterinary use in treating dermatological disorders
DK1448205T3 (da) 2001-10-05 2011-12-12 Zalicus Inc Kombinationer til behandling af immunoinflammatoriske sygdomme
US20030118655A1 (en) * 2001-12-21 2003-06-26 Nikhil Kundel Film forming liquid composition
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
WO2004000263A1 (en) 2002-06-25 2003-12-31 Acrux Dds Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
JPWO2004002452A1 (ja) * 2002-06-27 2005-10-27 ポーラ化成工業株式会社 医薬組成物
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US20040131662A1 (en) * 2003-11-12 2004-07-08 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US20040191302A1 (en) 2003-03-28 2004-09-30 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US8999372B2 (en) * 2002-11-14 2015-04-07 Cure Pharmaceutical Corporation Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
EP1426049B1 (en) * 2002-12-02 2005-05-18 Schwarz Pharma Ag Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
US20040265364A1 (en) * 2003-06-25 2004-12-30 Binnur Ozturk Neuropathy cream
US20050095277A1 (en) * 2003-06-25 2005-05-05 Binnur Ozturk Neuropathy cream
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
AU2004285335B2 (en) * 2003-10-23 2011-02-10 Cipla Limited Transdermal pharmaceutical spray formulations comprising a VP/VA copolymer and a non-aqueous vehicle
CA2568640C (en) 2004-06-04 2011-08-09 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing irbesartan
JP4705343B2 (ja) * 2004-07-09 2011-06-22 日東電工株式会社 経皮吸収製剤用基剤およびこれを用いた皮膚貼付製剤
KR101222903B1 (ko) * 2004-09-23 2013-01-16 다우 글로벌 테크놀로지스 엘엘씨 점막 또는 피부의 의료 또는 위생 시스템
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
WO2006119286A1 (en) * 2005-05-03 2006-11-09 Innozen, Inc. Edible film for transmucosal delivery of nutritional supplements
KR20130114229A (ko) 2005-06-03 2013-10-16 애크럭스 디디에스 피티와이 리미티드 경피 약물 전달 방법 및 조성물
GEP20125432B (en) 2005-10-12 2012-03-26 Unimed Pharmaceuticals Llc Improved testosterone gel and use thereof
US20070259029A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
US20070258935A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water dispersible films for delivery of active agents to the epidermis
US20080003213A1 (en) * 2006-05-22 2008-01-03 Jan Lessem Methods and compositions for the treatment of diseases or conditions associated with increased C-reactive protein, interleukin-6, or interferon-gamma levels
US20080057090A1 (en) * 2006-09-01 2008-03-06 Mcentire Edward Enns Wrinkle masking film composition for skin
US7879942B2 (en) * 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same
WO2008083423A1 (en) 2007-01-11 2008-07-17 Acrux Dds Pty Ltd Spreading implement
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
CA2737131A1 (en) * 2007-09-19 2009-03-26 Zalicus Inc. Therapeutic regimens for the treatment of immunoinflammatory disorders
MX2010006724A (es) * 2007-12-17 2010-09-07 Combinatorx Inc Regimenes terapeuticos para el tratamiento de desordenes inmunoinflamatorios.
US10080760B2 (en) * 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
JP5966261B2 (ja) * 2010-06-17 2016-08-10 大正製薬株式会社 外用組成物
CN102309447A (zh) * 2010-07-06 2012-01-11 上海现代药物制剂工程研究中心有限公司 含盐酸奥昔布宁的自粘性喷雾透皮组合物及制备方法
US8481591B2 (en) 2010-11-01 2013-07-09 Stiefel Research Australia Pty. Ltd. Polymeric topical compositions
JP6004364B2 (ja) * 2011-10-14 2016-10-05 大正製薬株式会社 皮膚外用剤
JP6285866B2 (ja) 2011-11-23 2018-02-28 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然複合ホルモン補充製剤および療法
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
JP2013147442A (ja) * 2012-01-18 2013-08-01 Kose Corp グリチルレチン酸ステアリルの皮膚浸透促進剤
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
RU2534521C2 (ru) * 2012-11-27 2014-11-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Национальный исследовательский Томский государственный университет" (ТГУ) Способ трансдермального введения инсулина и устройство для его осуществления
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
USD750788S1 (en) 2013-11-26 2016-03-01 Acrux Dds Pty Ltd Topical spreading applicator
USD749225S1 (en) 2013-11-26 2016-02-09 Acrux Dds Pty Ltd Topical spreading applicator
KR20170005819A (ko) 2014-05-22 2017-01-16 쎄러퓨틱스엠디, 인코퍼레이티드 천연 복합 호르몬 대체 제형 및 요법
RU2016141135A (ru) 2014-07-29 2018-08-28 Терапьютиксмд, Инк. Трансдермальный крем
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
DE102017104026A1 (de) * 2017-02-27 2018-08-30 Lts Lohmann Therapie-Systeme Ag Nicotin enthaltendes transparentes transdermales therapeutisches System
DE102017127433A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
WO2019140087A1 (en) * 2018-01-10 2019-07-18 Celista Pharmaceuticals Llc Testosterone transdermal spray with film
CN109394735B (zh) * 2018-11-09 2022-01-28 北京德默高科医药技术有限公司 具有高溶解度的布洛芬或其结构类似物经皮给药系统

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
US4624665A (en) * 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
US4764381A (en) * 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
FR2612785A1 (fr) * 1987-03-25 1988-09-30 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
EP0289900A1 (en) * 1987-04-30 1988-11-09 Abbott Laboratories Topical antibacterial compositions
JPH01503281A (ja) * 1987-05-27 1989-11-09 ブルグハルト，クルト 経皮治療に有効な医薬包帯剤およびこれを施用するためのデバイス
JPH07116035B2 (ja) * 1987-12-08 1995-12-13 塩野義製薬株式会社 被膜形成性抗真菌剤組成物
FR2635979B1 (fr) * 1988-09-07 1992-05-29 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5547662A (en) * 1993-08-27 1996-08-20 Becton, Dickinson And Company Preparation of a skin surface for a surgical procedure
KR960011044B1 (ko) * 1993-09-27 1996-08-16 재단법인 한국화학연구소 알칸올 투과가 우수한 고분자막

Also Published As

Publication number Publication date
CN1108790C (zh) 2003-05-21
SI0817621T2 (sl) 2008-06-30
DK0817621T4 (da) 2008-04-28
IS2537B (is) 2009-08-15
PL186004B1 (pl) 2003-09-30
EP0817621B1 (fr) 2001-06-20
FR2732223B1 (fr) 1997-06-13
BR9607862A (pt) 1998-06-30
CY2280B1 (en) 2003-07-04
TR199701083T1 (xx) 1998-02-21
IS4566A (is) 1997-09-22
CZ308197A3 (cs) 1998-04-15
CZ291914B6 (cs) 2003-06-18
ATE202280T1 (de) 2001-07-15
CA2214845A1 (fr) 1996-10-03
PL322502A1 (en) 1998-02-02
MX9707434A (es) 1997-12-31
TW442296B (en) 2001-06-23
CN1182365A (zh) 1998-05-20
KR19980703624A (ko) 1998-12-05
CA2214845C (fr) 2003-01-07
AU704150B2 (en) 1999-04-15
DE69613463T3 (de) 2008-07-24
KR100260237B1 (ko) 2000-08-01
IL117728A (en) 1999-08-17
SI0817621T1 (en) 2001-12-31
SK282634B6 (sk) 2002-10-08
GR3036630T3 (en) 2001-12-31
SK130697A3 (en) 1998-06-03
RU2161957C2 (ru) 2001-01-20
HU227957B1 (en) 2012-07-30
EP0817621B2 (fr) 2007-12-26
NO323583B1 (no) 2007-06-11
US6010716A (en) 2000-01-04
JPH11502828A (ja) 1999-03-09
HUP9904174A3 (en) 2000-06-28
DK0817621T3 (da) 2001-09-24
NZ305893A (en) 1999-11-29
FR2732223A1 (fr) 1996-10-04
NO974507D0 (no) 1997-09-29
WO1996030000A1 (fr) 1996-10-03
IL117728A0 (en) 1996-07-23
NO974507L (no) 1997-09-29
ZA962536B (en) 1997-09-29
AR001458A1 (es) 1997-10-22
ES2160239T5 (es) 2008-05-16
EP0817621A1 (fr) 1998-01-14
DE69613463T2 (de) 2002-06-06
AU5402296A (en) 1996-10-16
ES2160239T3 (es) 2001-11-01
DE69613463D1 (de) 2001-07-26
JP3778937B2 (ja) 2006-05-24
HUP9904174A2 (hu) 2000-04-28
PT817621E (pt) 2001-11-30

Similar Documents

Publication Publication Date Title
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
NO20004345D0 (no) Farmasøytisk sammensetning
FI973518A (fi) Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
NO961136D0 (no) Farmasöytisk formuleringsgrunnlag for nano-suspensjoner
FI954767A (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
PT1153626E (pt) Aparelho de administracao de medicamentos
DE69634053D1 (de) Oral anzuwendende Arzneizusammensetzung enthaltend 2-Methyl-thienobenzodiazepin
IS4706A (is) Lyfjasamsetningar
BR9610396A (pt) Formulação farmacêutica
BR9610214A (pt) Compostos farmacéuticos
DE69614407T2 (de) Pharmazeutische zusammensetzungen
LV11727A (lv) Farmaceitiska kompozicija
FI973229A0 (fi) Uusi farmaseuttinen koostumus
FI973280A0 (fi) Farmaseuttinen koostumus
FI973230A (fi) Uusi farmaseuttinen formulaatio
IT1280428B1 (it) Composizione farmaceutica per uso topico
NO971879D0 (no) Preparat for transdermal administrasjon
NO965448L (no) Farmasöytiske forbindelser
BR9605777A (pt) Composição farmacêutica
NO964309D0 (no) Farmasöytisk sammensetning
FI960435A0 (fi) Lääkkeiden transdermaalisen antotapaan tarkoitettuLääkkeiden transdermaalisen antotapaan tarkoitettu koostumus koostumus
FI964663A0 (fi) Farmaceutisk analgetisk komposition foer lokal administrering
FI950008A (fi) Farmaseuttinen koostumus kontrolloitua vapautumista varten
SE9402432D0 (sv) New pharmaceutical dosage form